These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 31404868)

  • 1. Enhancing the oral bioavailability of curcumin using solid lipid nanoparticles.
    Ban C; Jo M; Park YH; Kim JH; Han JY; Lee KW; Kweon DH; Choi YJ
    Food Chem; 2020 Jan; 302():125328. PubMed ID: 31404868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
    Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
    Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of the gastrointestinal digestion of solid lipid nanoparticles using PEGylated emulsifiers.
    Ban C; Jo M; Lim S; Choi YJ
    Food Chem; 2018 Jan; 239():442-452. PubMed ID: 28873589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
    Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
    Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galactosamine-modified PEG-PLA/TPGS micelles for the oral delivery of curcumin.
    Sun S; Du X; Fu M; Khan AR; Ji J; Liu W; Zhai G
    Int J Pharm; 2021 Feb; 595():120227. PubMed ID: 33484915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
    Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
    Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
    Patel MH; Mundada VP; Sawant KK
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
    [No Abstract]   [Full Text] [Related]  

  • 8. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.
    Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
    Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake.
    Baek JS; Cho CW
    Eur J Pharm Biopharm; 2017 Aug; 117():132-140. PubMed ID: 28412471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnesium lithospermate B loaded PEGylated solid lipid nanoparticles for improved oral bioavailability.
    Kang X; Chen H; Li S; Jie L; Hu J; Wang X; Qi J; Ying X; Du Y
    Colloids Surf B Biointerfaces; 2018 Jan; 161():597-605. PubMed ID: 29156336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles.
    Wang W; Zhu R; Xie Q; Li A; Xiao Y; Li K; Liu H; Cui D; Chen Y; Wang S
    Int J Nanomedicine; 2012; 7():3667-77. PubMed ID: 22888226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced oral delivery and anti-gastroesophageal reflux activity of curcumin by binary mixed micelles.
    Sun Y; Li Y; Shen Y; Wang J; Tang J; Zhao Z
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1444-1450. PubMed ID: 31170849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Submicron complex lipid carriers for curcumin delivery to intestinal epithelial cells: Effect of different emulsifiers on bioaccessibility and cell uptake.
    Yucel C; Quagliariello V; Iaffaioli RV; Ferrari G; Donsì F
    Int J Pharm; 2015 Oct; 494(1):357-69. PubMed ID: 26291881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
    Chen CC; Tsai TH; Huang ZR; Fang JY
    Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocophersolan stabilized lipid nanocapsules with high drug loading to improve the permeability and oral bioavailability of curcumin.
    Bapat P; Ghadi R; Chaudhari D; Katiyar SS; Jain S
    Int J Pharm; 2019 Apr; 560():219-227. PubMed ID: 30776407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake.
    Cho HJ; Park JW; Yoon IS; Kim DD
    Int J Nanomedicine; 2014; 9():495-504. PubMed ID: 24531717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
    Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
    J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers.
    Tian C; Asghar S; Wu Y; Chen Z; Jin X; Yin L; Huang L; Ping Q; Xiao Y
    Int J Nanomedicine; 2017; 12():7897-7911. PubMed ID: 29138557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin Containing PEGylated Solid Lipid Nanoparticles for Systemic Administration: A Preliminary Study.
    Santonocito D; Sarpietro MG; Carbone C; Panico A; Campisi A; Siciliano EA; Sposito G; Castelli F; Puglia C
    Molecules; 2020 Jun; 25(13):. PubMed ID: 32629951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.
    Harde H; Das M; Jain S
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.